News
- Author:
- Sara Freeman
Publish date: February 23, 2020
LONDON – By age 12, all children with recessive dystrophic epidermolysis bullosa had moderate to severe hand deformity with reduced finger flexion,...
News
- Author:
- Sara Freeman
Publish date: February 12, 2020
LONDON – Epidermolysis bullosa classification criteria have been reworked and are a further step in understanding the rare genetic disease.
News
- Author:
- Sara Freeman
Publish date: February 10, 2020
LONDON – Low-dose calcipotriol ointment significantly improved wound healing and itch in people with epidermolysis bullosa in a pilot study.
News
- Author:
- Sara Freeman
Publish date: February 4, 2020
LONDON – No safety concerns have been seen so far with the antihypertensive drug losartan in children with the skin blistering disease.
News
- Author:
- Sara Freeman
Publish date: February 3, 2020
LONDON – Dressing and bandage costs were highest for study participants with the generalized severe subtype, at about $112,450 per patient annually...
News
- Author:
- Sara Freeman
Publish date: December 10, 2019
BARCELONA – Studies show potential of cenicriviroc, tirzepatide, and exenatide plus dapagliflozin for nonalcoholi...
News
- Author:
- Sara Freeman
Publish date: November 8, 2019
Investigators say their retrospective study results demonstrate that each TNBC subtype is associated with specific tumor microenvironment profiles,...
News
- Author:
- Sara Freeman
Publish date: November 6, 2019
BARCELONA – Younger people with type 2 diabetes need a more focused treatment strategy, irrespective of cardiometabolic risk.
News
- Author:
- Sara Freeman
Publish date: November 6, 2019
BARCELONA – Data highlight an increase in prevalence at diagnosis, but certain factors may help identify those most at risk.
News
- Author:
- Sara Freeman
Publish date: November 4, 2019
BARCELONA – Disturbed HDL cholesterol metabolism may be one of the earliest features of type 2 diabetes.
News
- Author:
- Sara Freeman
Publish date: November 4, 2019
BARCELONA – Patients with a high body mass index gain the most benefit from sodium-glucose cotransporter 2 inhibitors added to insulin.
News
- Author:
- Sara Freeman
Publish date: October 29, 2019
BARCELONA – There was no difference in pancreatic beta-cell function as measured by meal-stimulated C-peptide levels.
News
- Author:
- Sara Freeman
Publish date: October 28, 2019
BARCELONA – Once-weekly treatment with subcutaneous semaglutide yielded greater reductions in HbA1c and body weight than once-daily lira...
News
- Author:
- Sara Freeman
Publish date: October 18, 2019
BARCELONA – Obesity has a dominant effect on the risk of type 2 diabetes over other risk factors, regardless of g...
News
- Author:
- Sara Freeman
Publish date: October 2, 2019
BARCELONA – ELLIPSE trial shows clinicians aren’t limited to metformin and insulin for children with diabetes.
